Physician profile
Yolanda J Yoder
NPI 1730298746
$3,066.89
in general payments reported to CMS, 2019-2025
39 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $214 · 2021: $405 · 2022: $440 · 2023: $525 · 2024: $479 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,393.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $459.81 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $381.02 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $258.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sunovion Pharmaceuticals INC. | $248.22 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $216.67 | 2019-2025 | Breztri, Airsupra |
| Allergan, INC. | $155.66 | 2019-2020 | |
| Alkermes, INC. | $133.61 | 2021-2025 | Aristada, Lybalvi |
| Glaxosmithkline, LLC. | $109.55 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $105.62 | 2019-2025 | |
| Amgen INC. | $89.82 | 2023-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $71.45 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.86 | 2020-2024 | Trintellix, Gattex |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.00 | 2023-2024 | Caplyta |
| Exact Sciences Corporation | $51.04 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medicines360 | $50.00 | 2019 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolanda Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.